Skip to main content
Search
Explore journals
Get published
About BMC
My account
Search all BMC articles
Search
Neurological Research and Practice
Home
About
Articles
Submission Guidelines
Table 5 Dosage Details as Recommended for Remission-Maintenance Immunosuppressive Therapy [
42
,
43
,
56
,
64
]
From:
Cerebral involvement in systemic vasculitides
AZA
2 mg/kg oral daily
MTX
20–25 mg oral or parenteral weekly
RTX
500 mg i.v. on day 0 and 14, then every 6 months
Leflunomid
20–30 mg oral daily
MMF
2 g oral daily
Back to article page